Preclinical antitumor activity of BMS-599626, a pan-HER kinase inhibitor that inhibits HER1/HER2 homodimer and heterodimer signaling.

Tai W Wong; Francis Y Lee; Chiang Yu; Feng R Luo; Simone Oppenheimer; Hongjian Zhang; Richard A Smykla; Harold Mastalerz; Brian E Fink; John T Hunt

doi:10.1158/1078-0432.CCR-06-0642

Preclinical antitumor activity of BMS-599626, a pan-HER kinase inhibitor that inhibits HER1/HER2 homodimer and heterodimer signaling.

Identifier:nobleid.org/w1/20260515/CFCB40C3

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/CFCB40C3.svg?ark=w1%2F20260515%2FCFCB40C3)](https://nobleid.org/work/w1/20260515/CFCB40C3)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Preclinical antitumor activity of BMS-599626, a pan-HER kinase inhibitor that inhibits HER1/HER2 homodimer and heterodimer signaling.

Identifier:nobleid.org/w1/20260515/CFCB40C3

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/CFCB40C3.svg?ark=w1%2F20260515%2FCFCB40C3)](https://nobleid.org/work/w1/20260515/CFCB40C3)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work